Stock Research: PolyNovo

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

PolyNovo

ASX:PNV AU000000PNV0
23
  • Value
    14
  • Growth
    83
  • Safety
    Safety
    7
  • Combined
    12
  • Sentiment
    56
  • 360° View
    360° View
    23
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

PolyNovo Limited is an Australia-based medical device company focused on advanced wound care, designing, developing, and manufacturing dermal regeneration solutions. Its main businesses include NovoSorb Biodegradable Temporizing Matrix (BTM) and NovoSorb MTX, used for managing various wounds. In the last fiscal year, the company had a market cap of $538 million, profits of $66 million, revenue of $70 million, and 254 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 23 (better than 23% compared with alternatives), overall professional sentiment and financial characteristics for the stock PolyNovo are critical, mostly below average. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for PolyNovo. The consolidated Growth Rank has a good rank of 83, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is higher than for 83% of competitors in the same industry. The consolidated Sentiment Rank also has a good rank of 56, which means that professional investors are more optimistic about the stock than for 56% of alternative investment opportunities. But the consolidated Value Rank has a less desirable rank of 7, which means that the share price of PolyNovo is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 93% of alternative stocks in the same industry. Finally, the consolidated Safety Rank has a riskier rank of 14, which means that the company has a financing structure that is riskier than those of 86% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. ...read more

more
Index
ASX 200
ASX 300
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 21-Aug-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Growth
Shows a company's growth potential.
High Growth Tough Times
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
7 7 6 3
Growth
83 56 97 45
Safety
Safety
14 15 12 4
Sentiment
56 57 51 41
360° View
360° View
23 15 23 1
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
54 49 55 55
Opinions Change
43 50 72 50
Pro Holdings
n/a 51 40 50
Market Pulse
61 64 53 38
Sentiment
56 57 51 41
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
7 7 6 3
Growth
83 56 97 45
Safety Safety
14 15 12 4
Combined
12 4 21 1
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
8 10 5 3
Price vs. Earnings (P/E)
24 11 9 5
Price vs. Book (P/B)
7 3 3 1
Dividend Yield
1 1 1 1
Value
7 7 6 3
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
98 91 96 100
Profit Growth
60 80 94 75
Capital Growth
98 1 98 1
Stock Returns
1 51 23 17
Growth
83 56 97 45
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
42 40 41 24
Refinancing
19 9 17 5
Liquidity
24 18 12 6
Safety Safety
14 15 12 4

Similar Stocks

Discover high‑ranked alternatives to PolyNovo and broaden your portfolio horizons.

Nipro

TSE:8086
Country: Japan
Industry: Health Care Supplies
Size: Large
Full Stock Analysis

Asahi Intecc

TSE:7747
Country: Japan
Industry: Health Care Supplies
Size: Medium
Full Stock Analysis

M3

TSE:2413
Country: Japan
Industry: Health Care Technology
Size: Medium
Full Stock Analysis

Suncorp

ASX:SUN
Country: Australia
Industry: Property & Casualty Insurance
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.